Zhejiang Hisoar Pharmaceutical Co. Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisoar Pharmaceutical Co. Ltd with three other
companies in this sector in China:
Guangxi Wuzhou Zhongheng Group, Ltd.
sales of 2.05 billion Chinese Renmimbi [US$302.71 million]
of which 93%
was Pharmaceutical Segment),
Anhui Fengyuan Pharmaceutical
(2.58 billion Chinese Renmimbi [US$381.38 million]
of which 58%
was Medicine Retail Circulation), and
Xiangxue Pharmaceutical Co Ltd
(2.19 billion Chinese Renmimbi [US$323.57 million]
of which 37%
was Chinese Herbal Medicines).
Zhejiang Hisoar Pharmaceutical Co. Ltd reported sales of 2.31 billion Chinese Renmimbi (US$341.56 million)
December of 2017.
decrease of 5.1%
versus 2016, when the company's sales were 2.43 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 16.1% decline
in Others, from 19.22 million Chinese Renmimbi to 16.13 million Chinese Renmimbi.
There were also decreases in sales in
Dyes (down 10.7% to 1.08 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Pharmatheutical Industry (up 2.7% to 1.29 billion Chinese Renmimbi)